This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56775297
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 2012 article scientifique publié en 2012 im Februar 2012 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q56775297-63AED9F7-2B90-48C2-87F6-025C704855F3
wdt:P577
2012-02-01T00:00:00Z
p:P407
wds:Q56775297-4816E8D6-7C36-44BB-9A2E-51CC24B34FCF
wdt:P407
wd:Q1860
p:P2888
wds:Q56775297-399ACF94-5E01-4184-962A-D2B22032532F
wdt:P2888
n7:s00280-011-1728-3
p:P2860
wds:Q56775297-56939DA6-B0AC-43EF-BAA7-FC2D6CABBCB3 wds:Q56775297-631E77F4-EFDB-4B4D-A995-B05F37001CA8 wds:Q56775297-DD57B140-F575-4079-95A3-11C3629BC5F0 wds:Q56775297-E46EC6EC-2E6C-48D7-ADD4-036576C356C5 wds:Q56775297-EF8D14CD-BB0C-46EB-B96E-FBDA24B4E2C8 wds:Q56775297-F78A5AE3-3D38-4C4B-AF29-36195A16D997 wds:Q56775297-D3046149-C904-41C7-B0C5-94E3C5C0C1DC wds:Q56775297-D60B4760-9525-4CC0-8175-45B64BA574FA wds:Q56775297-DA08CF1A-ED0F-4608-8D5B-208B34FC6914 wds:Q56775297-DA52D635-E6B0-467E-B9AD-1E609A4D023E wds:Q56775297-C1B8424D-48F2-4BEF-935B-3CC6792270AF wds:Q56775297-C6F33899-5076-4419-9814-ECD97C99C618 wds:Q56775297-C9B0B3B8-0F2D-4A06-AF5F-8DDEBA876510 wds:Q56775297-D29B19BE-2719-4952-A98C-EA840CEC80DE wds:Q56775297-AA94BEDE-D9E8-42FE-A373-BED1207E3C6A wds:Q56775297-BCBF2F4E-675E-4D6B-8B8F-166C27DF13C0 wds:Q56775297-FA6A4CB0-36DF-4BBA-A63A-9520DC3C4ABC wds:Q56775297-062F50CF-50BA-46EC-96B0-3005910F1558 wds:Q56775297-066E7739-571E-409A-9DB1-604FC890AFF5 wds:Q56775297-46FCC79D-7144-4E3B-ADCA-039960ED251D wds:Q56775297-53C0B8E6-7713-4087-9249-CA712C001CE7 wds:Q56775297-3D567D13-93E6-44A4-9577-F251B07B5B2C wds:Q56775297-44B4BB59-DE97-4B9B-8C7F-FF2E99994B68 wds:Q56775297-46E4B67A-155F-493B-AD6E-98DAC00E157F wds:Q56775297-28C9AFD9-2F41-450E-B14D-8DB880596D80 wds:Q56775297-36CD3BE1-F10F-4335-A35A-CA55C191F5D8 wds:Q56775297-17F1264A-5CD8-4FD2-9E9C-6D9884DAA7E9 wds:Q56775297-1C2A0258-7AC5-4C19-B90D-D21C647E20AE wds:Q56775297-284D61BE-1B0E-427A-94AF-6BDB2D680F71 wds:Q56775297-92664B3F-C7FE-4B3A-B78B-7D5528D19FC7 wds:Q56775297-98FCB004-CDA2-4E7A-810B-FE7E09C0E110 wds:Q56775297-A15A42C0-C3FF-4D19-9F7A-B5A26EB41A82 wds:Q56775297-7BF248DE-4C29-4FE0-A8EA-70421E3E111B
wdt:P2860
wd:Q46828994 wd:Q33367124 wd:Q34285880 wd:Q46830983 wd:Q44963911 wd:Q37150060 wd:Q44910538 wd:Q27851403 wd:Q46798675 wd:Q34524041 wd:Q58211907 wd:Q33382437 wd:Q34162335 wd:Q44764054 wd:Q40915962 wd:Q43824330 wd:Q27851468 wd:Q36125318 wd:Q46487415 wd:Q33631745 wd:Q43293573 wd:Q36024588 wd:Q33387849 wd:Q43258971 wd:Q37577641 wd:Q46410460 wd:Q44525923 wd:Q46613445 wd:Q28255226 wd:Q33378298 wd:Q51906120 wd:Q52925550 wd:Q33855276
p:P2093
wds:Q56775297-AC7207E8-41B4-4D0A-AB6B-78EF730CFEBA wds:Q56775297-A8BAFED1-68D4-4A06-8A8F-90698D1170D9 wds:Q56775297-8AEF2ECB-BEEE-4FC3-8968-7AA28D928430 wds:Q56775297-7ED60173-2294-48A5-8118-A599DBE13B1A wds:Q56775297-9EEC82DF-9DB0-43F0-83E0-ED736D83E6E9 wds:Q56775297-698376E9-255E-44C6-867A-3E32FDFB9F67 wds:Q56775297-417239AA-ED24-4594-A9E3-DE744AA51C2D
wdt:P2093
Shiangjiin Leaw Jingsong Lu Jialei Wang Zhonghua Wang Xichun Hu Zhimin Shao Xiaonan Hong
rdfs:label
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
skos:prefLabel
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
schema:name
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
p:P1476
wds:Q56775297-16A1C609-51AF-4536-9E00-1A06D6C41D64
wdt:P1476
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
p:P304
wds:Q56775297-274897FF-51DE-4F23-9069-ACA54EA99A9C
wdt:P304
515-22
p:P31
wds:Q56775297-4AFA08AE-021B-4647-AC6A-E6181518C233
wdt:P31
wd:Q13442814
p:P921
wds:Q56775297-3BA3AF6C-D1F0-4D1C-A74C-1039ABD62107 wds:Q56775297-57F15851-358A-4A5B-8F79-86FCC5464A4A
wdt:P921
wd:Q12859063 wd:Q420207
p:P698
wds:Q56775297-7F8C2A9D-4B05-4ADD-A47D-A7DC1E4B5046
wdtn:P698
n10:21874317
wdt:P698
21874317
p:P1433
wds:Q56775297-72ABB2F0-7BDF-4627-B55B-70E5D634B29B
wdt:P1433
wd:Q326137
p:P433
wds:Q56775297-6430CC3D-6759-4B5B-956F-7D7E78D82A6A
p:P478
wds:Q56775297-023DE3D5-5CCB-41AA-9252-65D76D02778D
wdt:P433
2
wdt:P478
69
p:P356
wds:Q56775297-70C7937E-98A4-4476-B56B-D2A67485EE43
wdtn:P356
n11:S00280-011-1728-3
wdt:P356
10.1007/S00280-011-1728-3